New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 16, 2014
09:23 EDTFOX, TXT, HCA, WAC, ABT, ARCC, NSM, PDS, MLNX, YHOO, FOXA, FEYE, IBM, TWX, MTG, INTC, AAPLOn The Fly: Pre-market Movers
HIGHER: Time Warner (TWX), up 15% after company confirmed that it rejected an $80B takeover offer from 21st Century Fox (FOX, FOXA), as had been reported earlier this morning... Apple (AAPL), up 2% after announcing an enterprise mobile partnership with IBM (IBM), which is also up 2%... International Game (IGT), up 9.5% after agreeing to be acquired by GTECH for $4.7B in cash and stock... FireEye (FEYE), up 5% after shares upgraded at Goldman... Precision Drilling (PDS), up 4% after announcing strategic agreement with Schlumberger (SLB), upgraded at Deutsche Bank... Mellanox (MLNX), up 4.7% following upgrade at Jefferies. UP AFTER EARNINGS: Intel (INTC), up 5.4%... HCA Holdings (HCA), up 6%... Textron (TXT), up 3.2%... Abbott (ABT), up 1%. DOWN AFTER EARNINGS: PNC Financial (PNC), down 2.5%... MGIC Investment (MTG), down 3.6%. LOWER: Yahoo (YHOO), down 3% after downgraded at CRT Capital following second quarter earnings report... Ares Capital (ARCC), down 2.5% after filing to sell 11.85M shares of common stock... Nationstar (NSM), down 2.4% after downgraded at Wells Fargo... Walter Investment (WAC), which was also downgraded at Wells Fargo, down 1.6%.
News For TWX;FOXA;AAPL;IBM;YHOO;INTC;FEYE;MLNX;MTG;ARCC;HCA;PDS;ABT;TXT;NSM;WAC;FOX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | all recent news | >>
July 20, 2015
13:37 EDTAAPLApple July weekly volatility increases into Q3 and outlook
Apple July weekly call option implied volatility is at 56, August is at 31, October is at 26; compared to its 52-week range of 15 to 36, suggesting large near term price movement into the expected release of Q3 results on July 21.
13:28 EDTAAPLSamsung most popular smartphone maker in Q2, TrendForce says
Samsung (SSNLF) was the most popular smartphone maker in the second quarter, even though the smartphone market has started to slow down, according to data from research firm TrendForce. Smartphone shipments will grow 8.2% year over year in 2015, though that's down from the previously anticipated growth rate of 11.6%, the report says. Samsung has led in smartphone shipments with a second-quarter growth of 26.8%. However, Galaxy S6 and S6 Edge's annual shipment forecast has been marked down repeatedly. TrendForce has also revised Samsung's annual smartphone shipments downwards to 45M units this year. As Chinese vendors are taking more shares of the low- to mid-range product market, Samsung's ability to reverse its fortune may hinge on the success of its Galaxy Note 5. If this device is able to attract consumers with upgraded specs and new features, then Samsung will avoid the high possibility of negative shipment growth for this year. Apple (AAPL) rode on the popularity of iPhone 6 and iPhone 6 Plus in this year's first half and achieved a remarkably strong shipment result in the off-peak season. The next-generation iPhone due to be launched this year offers no major changes in appearance, but Apple has given the device a new A9 processor and upgraded its memory to 2GB LPDDR4 for the first time. These improvements along with the Force Touch module and a camera featuring a possible resolution of 12MP will give the next iPhone a huge boost. Thus, TrendForce's iPhone shipment forecast for this year continues to be very positive with a high growth of 15% upwards. Lenovo (LNVGY) has fallen to No. 6 in the global shipment ranking and is expected to see a 20%-30% decline in this year's shipments. Lenovo's market share did not double as anticipated after its takeover of Motorola in 2014. Moreover, Lenovo did not have a well-defined product positioning strategy and the brand faced strong competition from challengers offering lower-priced smartphone models.
12:40 EDTIBM, AAPLEarnings Watch: IBM up 4% since last quarterly report
Subscribe for More Information
12:20 EDTYHOOYahoo July weekly volatility increases into Q2 and outlook
Subscribe for More Information
10:45 EDTIBMIBM technical comments ahead of earnings
Subscribe for More Information
10:13 EDTMTGOptions with decreasing implied volatility
Subscribe for More Information
10:07 EDTAAPLApple rallies ahead of earnings
Shares are up over 1.3% to $131.41 at time of writing. At that price next resistance is at $134.54, the life high. Support is at $130.50.
10:00 EDTFOXAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:34 EDTINTC, AAPLActive equity options trading on open
Subscribe for More Information
09:02 EDTABTAbbott receives FDA approval and launches iDesign Advanced WaveScan system
Subscribe for More Information
08:38 EDTABTAnalyst predicts Zoetis merges with Bayer unit, not Valeant
Zoetis (ZTS) in recent months has been the subject of takeover speculation, possibly for Valeant (VRX), but a Jefferies analyst told investors today in a research note that he views a deal with a unit of healthcare giant Bayer (BAYRY) as "highly likely" for the animal medicine company. BACKGROUND: Bill Ackman of Pershing Square, who owns stakes in both Zoetis and Valeant, said in early May while speaking on CNBC that Zoetis is a "great” business on a standalone basis, but he also spoke of the company's strategic value. Ackman added, however, that he was "not sure" that Valeant was the best acquirer of Zoetis. Subsequently, in late June, The Wall Street Journal reported that Valeant made a preliminary approach regarding a potential deal to buy Zoetis. CNBC's David Faber said the next day, citing his own sources, that Valeant reached out to Zoetis as a courtesy to common shareholder Ackman and was unlikely to pursue an acquisition of the company, though he cautioned then Valeant could change its approach and pursue a deal. BAYER: Jefferies analyst Jeffrey Holford said in a note today that he views a tie-up between Zoetis and Bayer's Animal Health business in 2016 as "highly likely." He sees Mylan's (MYL) acquisition of Abbott's (ABT) non‑U.S. developed markets specialty and branded generics business as a potential proxy for how a transaction could be structured, adding that such a "spinversion" could achieve up to 36% long-term earnings accretion for Zoetis. Holford reiterated a Buy rating on Zoetis with a $60 price target, while downgrading Bayer to Hold, citing valuation following the recent outperformance of its shares. IDEXX: While being discussed as a target, some analysts have also opined on companies that Zoetis could pursue as a buyer. On June 29, Canaccord said that in investor meetings with IDEXX (IDXX) executives declined to comment on Zoetis' potential interest in scaling up its animal health diagnostics business. Canaccord added that it thought Zoetis could make a bid for IDEXX. The firm reiterated its Buy rating and $80 price target on IDEXX shares at that time. PRICE ACTION: Since June 25, the day the Journal first reported on Valeant's preliminary takeover approach to Zoetis, the animal health company's shares have dropped nearly 4%. Zoetis closed down 20c to $47.80 on Friday.
07:33 EDTABTInternational AIDS Society to hold a conference
Subscribe for More Information
07:30 EDTABTZoetis 'highly likely' to merge with Bayer unit in 2016, says Jefferies
Subscribe for More Information
06:59 EDTYHOOYahoo says taxes could 'materially reduce' Aabaco cash for distributions
Subscribe for More Information
06:48 EDTAAPLApple in talks to create free streaming TV channel, NY Post reports
Subscribe for More Information
06:39 EDTAAPLNew iPods won't run Apple Music to prevent piracy, 9to5Mac reports
Subscribe for More Information
06:31 EDTAAPLAnalysts down on Apple Watch sales, AFP reports
Certain analysts have said that Apple's new smartwatch is not a mainstream hit due its disappointingly low sales figures, AFP reports. A study from Slice Intelligence suggests that Apple Watch orders have decreased 90% since the week the device made its debut, the report says. In response, BMO Capital Markets said it told investors that they were "disappointed" and reduced their estimate for Apple Watch sales in the upcoming year, the report adds. Richard Windsor at Edison Investment Research said that even if Slice is off the mark about the plunge in Apple Watch orders, it was evident that the wearable has sold way less than even conservative expectations, AFP says. Reference Link
06:25 EDTFOXA21st Century Fox downgraded to Neutral from Outperform at Macquarie
Macquarie downgraded 21st Century Fox to Neutral and lowered its price target to $34 from $40. The firm sees uncertainty around FY16 earnings given increasing programming costs, further investments, and potential acquisitions, and has a mixed views on the company's OTT streaming position.
06:22 EDTAAPLApple July weekly volatility elevated into Q3 and outlook
Subscribe for More Information
05:57 EDTAAPLApple iPhone momentum to continue in June quarter, says Piper Jaffray
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use